SCHEMBL30764735

SCHEMBL30764735

O=C(Cc1ccc(Cl)cc1)N1CC2(CN(Cc3ccc(F)c(F)c3)C2)C1

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.51
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
GPR183 P32249 4/20 0.44
MLNR O43193 2/20 0.44
SIGMAR1 Q99720 3/20 0.43
ATM Q13315 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HTT P42858 1/20 0.43
DRD1 P21728 1/20 0.42
DRD3 P35462 1/20 0.42
TMEM97 Q5BJF2 1/20 0.42
GFER P55789 1/20 0.41
FAAH O00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764707 0.85 HSD11B1 (0.55) HSD11B1KMT2AMEN1GPR183SIGMAR1
SCHEMBL30764755 0.79 GAA (0.54) HSD11B1KMT2AMEN1ALDH1A1
SCHEMBL30764702 0.78 GHSR (0.46) HSD11B1KMT2AMEN1ALDH1A1FAAH
SCHEMBL30764715 0.78 HSD11B1 (0.51) HSD11B1KMT2AMEN1GPR183ATM
SCHEMBL30764734 0.78 KMT2A (0.54) HSD11B1KMT2AMEN1GPR183ATM
SCHEMBL27253361 0.77 HSD11B1 (0.45) HSD11B1KMT2AMEN1MLNRSIGMAR1
SCHEMBL30764757 0.76 HSD11B1 (0.46) HSD11B1KMT2AMEN1ATMALDH1A1
SCHEMBL30764754 0.76 HSD11B1 (0.46) HSD11B1KMT2AMEN1SIGMAR1ATM
SCHEMBL30764763 0.76 HSD11B1 (0.46) HSD11B1KMT2AGPR183FAAH
SCHEMBL30764758 0.75 KDM4E (0.59) HSD11B1KMT2AMEN1GPR183ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed